Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 22;12(1):32.
doi: 10.1186/s13065-018-0401-x.

QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors

Affiliations

QSAR study and rustic ligand-based virtual screening in a search for aminooxadiazole derivatives as PIM1 inhibitors

Adnane Aouidate et al. Chem Cent J. .

Abstract

Background: Quantitative structure-activity relationship (QSAR) was carried out to study a series of aminooxadiazoles as PIM1 inhibitors having pki ranging from 5.59 to 9.62 (k i in nM). The present study was performed using Genetic Algorithm method of variable selection (GFA), multiple linear regression analysis (MLR) and non-linear multiple regression analysis (MNLR) to build unambiguous QSAR models of 34 substituted aminooxadiazoles toward PIM1 inhibitory activity based on topological descriptors.

Results: Results showed that the MLR and MNLR predict activity in a satisfactory manner. We concluded that both models provide a high agreement between the predicted and observed values of PIM1 inhibitory activity. Also, they exhibit good stability towards data variations for the validation methods. Furthermore, based on the similarity principle we performed a database screening to identify putative PIM1 candidates inhibitors, and predict their inhibitory activities using the proposed MLR model.

Conclusions: This approach can be easily handled by chemists, to distinguish, which ones among the future designed aminooxadiazoles structures could be lead-like and those that couldn't be, thus, they can be eliminated in the early stages of drug discovery process.

Keywords: Aminooxadiazoles; Applicability domain; MLR; PIM1; QSAR model; Virtual screening.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The chemical structure of the studied compounds
Fig. 2
Fig. 2
Graphical representation of predicted and observed activity (pki) values calculated by MLR
Fig. 3
Fig. 3
Graphical representation of predicted and observed activity (pki) values calculated by MNLR
Fig. 4
Fig. 4
Williams plot for the training set and external validation for the PIM1 inhibitory activity of aminooxadiazole compounds, listed in Table 1 (h* = 0.44 and residual limits ± 2)
Fig. 5
Fig. 5
Reference structure of aminooxadiazole model with lowest binding constant ki
Fig. 6
Fig. 6
Leverage values of the screened compounds from the PubChem database for the PIM1 inhibitory activity, listed in Table 7 (h* = 0.44)

References

    1. Nawijn MC, Alendar A, Berns A. For better or for worse: the role of Pim oncogenes in tumorigenesis. Nat Rev Cancer. 2011;11:23–34. doi: 10.1038/nrc2986. - DOI - PubMed
    1. Santio NM, Vahakoski RL, Rainio E-M, et al. Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion. Mol Cancer. 2010;9:279. doi: 10.1186/1476-4598-9-279. - DOI - PMC - PubMed
    1. Brault L, Gasser C, Bracher F, et al. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica. 2010;95:1004–1015. doi: 10.3324/haematol.2009.017079. - DOI - PMC - PubMed
    1. Wu B, Wang HL, Cee VJ, et al. Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitors. Bioorg Med Chem Lett. 2015;25:775–780. doi: 10.1016/j.bmcl.2014.12.091. - DOI - PubMed
    1. Gadewal N, Varma A. Targeting Pim-1 kinase for potential drug-development. Int J Comput Biol Drug Des. 2012;5:137–151. doi: 10.1504/IJCBDD.2012.048303. - DOI - PubMed

LinkOut - more resources